Clinical impact of copy number variation changes in bladder cancer samples | Zendy

Victoria Spasova | Zendy; Boris Mladenov | Zendy; Simeon Rangelov | Zendy; Zora Hammoudeh | Zendy; Desislava Nesheva | Zendy; Dimitar Serbezov | Zendy; Rada Staneva | Zendy; Savina Hadjidekova | Zendy; Mihail Ganev | Zendy; Lubomir Balabanski | Zendy; Radoslava Vazharova | Zendy; Chavdar Slavov | Zendy; Драга Тончева | Zendy; Olga Antonova | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical impact of copy number variation changes in bladder cancer samples

Author(s) -

Victoria Spasova,

Boris Mladenov,

Simeon Rangelov,

Zora Hammoudeh,

Desislava Nesheva,

Dimitar Serbezov,

Rada Staneva,

Savina Hadjidekova,

Mihail Ganev,

Lubomir Balabanski,

Radoslava Vazharova,

Chavdar Slavov,

Драга Тончева,

Olga Antonova

Publication year - 2021

Publication title -

experimental and therapeutic medicine

Language(s) - English

Resource type - Journals

eISSN - 1792-1015

pISSN - 1792-0981

DOI - 10.3892/etm.2021.10333

Subject(s) - loss of heterozygosity , biology , bladder cancer , copy number variation , comparative genomic hybridization , genome instability , cancer research , cancer , chromosome instability , metastasis , molecular medicine , gene dosage , gene , genome , oncology , pathology , genetics , dna , medicine , allele , dna damage , cell cycle , chromosome , gene expression

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research